Skip links

NICE Guidelines for EMDA

National Institute for Health and Care Excellence (NICE)

What is NICE?

NICE provides guidance and advice to improve health and social care. The way NICE was established in legislation means that this guidance is officially England-only. However, there are agreements to provide certain NICE products and services to Wales, Scotland and Northern Ireland. The website can be viewed here.

How does NICE work?

NICE’s role is to improve outcomes for people using the NHS and other public health and social care services. Since 1999, NICE has provided the NHS, and those who rely on it for their care, with an increasing range of advice on effective, good value healthcare by:

What are NICE guidelines?

NICE guidelines make evidence-based recommendations on a wide range of topics, from preventing and managing specific medical conditions to planning broader services and interventions to improve the health of communities.

Does NICE issue licences?

NICE does not issue licences for medical products. Based on evidence presented to NICE and a defined set of principles, NICE makes recommendations based on:

  • the trade-off between the benefits and harms of an intervention
  • the quality of the underpinning evidence

Staff working in the NHS are expected to follow this guidance.

Has NICE issued guideance on the EMDA® treatment?

NICE published guidance on the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) in 2008. After analysing different studies into the treatment of NMIBC by Electrically-stimulated intravesical chemotherapy, NICE concluded that insufficient evidence had been presented though there are no major safety concerns about the procedure. The recommendation was that the treatment be offered as part of a research study.

NICE Interventional procedures guidance [IPG277]

More information

National Institute for Health and Care Excellence (NICE)

NHS Choices

PALS (Patient Advice and Liaison Service)

Are you a healthcare professional? Contact us for further information

Contact

The EMDA® system is manufactured in Italy and is in full compliance with all current European Medical Device Directives, with Class II Device CE-Mark.

EMDA® conforms to all our technical, clinical and ethical standards whilst offering healthcare institutions a better clinical results and remarkable cost-benefit value proposition.

Treatment FAQ's

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Guideline in NICE

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Treatment Centres

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Patient group info

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

More Products

Medical

Medical

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

LEARN MORE
AB-CT

AB-CT

Cutting-edge breast imaging.

LEARN MORE
Physion

Physion

Superior treatment for NMI bladder cancer.

LEARN MORE
Egg Medical

Egg Medical

90% reduction in scatter radiation.

LEARN MORE